We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Tiffany Haverly Tiffany Haverly is a director, public affairs, at PhRMA and develops communications strategies in support of PhRMA’s state advocacy efforts. Before joining PhRMA in 2018, she worked on Capitol Hill for over a decade as a senior advisor and communicator. Tiffany is a native Tennessean and proud Volunteer. She enjoys traveling with her husband and spoiling their rescue dog, Bailey.
This week, the U.S. Department of Health and Human Services and the U.S. Food and Drug Administration announced their “Safe Importation Action Plan.” While patients are rightfully concerned about...
PhRMA remains committed to working with lawmakers to ensure patients can afford and access their medicines, but importation schemes that put patient safety at risk will never be the right approach.
PhRMA is committed to working with lawmakers to ensure patients can access and afford their medicines, but importation schemes that put patient safety at risk are the wrong approach. In a recent...
Updated 3/5/2019 Ensuring patients receive already negotiated savings on their medicines could save certain patients across seven states up to $2,360 a year, according to new analyses from Milliman
Pharmaceutical Research and Manufacturers of America® 950 F Street, NW Suite 300, Washington, DC 20004